EN DE
STOCK COMPARISON

Meihao Medical Group Co. vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Meihao Medical Group Co. (1947) and HCA Healthcare (HCA) compare, as of Oct 1, 2026.

As of Oct 1, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Meihao Medical Group Co. trades at HK$0.54 versus a fair value of HK$0.37 (−31.5%), while HCA Healthcare trades at $427 versus $598 (+40.1%).
Meihao Medical Group Co.
1947.HK · HKD · Health Care
−31.5%
upside to fair value
overvalued
PriceHK$0.54
Fair ValueHK$0.37
Quality57/100
HCA Healthcare
HCA · USD · Health Care
+40.1%
upside to fair value
undervalued
Price$427
Fair Value$598
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Meihao Medical Group Co.HCA Healthcare
Valuation
n/aP/E (TTM)14.8×
n/aForward P/E (FY2027)13.3×
n/aMedian P/E at FY-end (10 FY, reported earnings)14.0×
0.41×P/S (TTM)1.22×
0.39×P/BNegative equity
n/aEV/EBITDA8.6×
n/aPEG1.34×
−31.5%Fair value upside+40.1%
1.8%Dividend yield0.7%
n/aDividend per share$3.00
Profitability
-19.7%Operating margin15.2%
n/aEBIT margin trend (5Y)1.12×
-12.4%Return on equityNegative equity
-7.0%Return on assets12.3%
Growth
42.2%Revenue growth (YoY)8.7%
-7.2%Avg. growth/yr (3Y)7.9%
3.8%Avg. growth/yr (5Y)8.0%
n/aValue creation/yr+16.7%
Balance & size
n/aInterest coverage (EBIT/interest)5.3×
0.12×Debt / equityNegative equity
$41MMarket cap$95B
weakGrowth qualityhealthy
HCA Healthcare, median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 14.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.

HCA Healthcare leads: 2 to 6 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Meihao Medical Group Co.of which business quality 58 · market factors 82 HCA Healthcareof which business quality 67 · market factors 44
ProfitabilityMargins and returns on capital today
15
76
Quality GrowthAre margins and returns improving?
95
61
CashflowEarnings quality: real cash, not paper profit
34
62
Fin. StrengthBalance sheet, leverage, solvency risk
96
41
InvestmentDisciplined investing over empire-building
87
75
Low VolatilityCalm price path (market factor)
66
59
MomentumPrice trend over the last 3–12 months (market factor)
87
40
52W MomentumDistance to the 52-week high (market factor)
91
36
Net IssuanceShare count: buybacks or dilution?
45
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMeihao Medical Group Co.Price HK$0.54HCA HealthcarePrice $427
DCF Models−33.3%below the priceHK$0.36+44.1%above the price$615
Earnings-Basedn/a−32.2%below the price$289
Dividend Discount−67.6%below the priceHK$0.18−87.4%below the price$53.85
Multiples−44.4%below the priceHK$0.30+57.7%above the price$673
Asset-Based−74.1%below the priceHK$0.14n/a
Growth DCF−29.6%below the priceHK$0.38+50.6%above the price$643
Economic Profitn/a−1.9%close to the price$419
Growth Earningsn/a+18.7%above the price$506
Minimum−74.1%below the priceHK$0.14−87.4%below the price$53.85
Maximum−29.6%below the priceHK$0.38+57.7%above the price$673
Median−44.4%below the priceHK$0.30+18.7%above the price$506
Geometric mean−53.4%below the priceHK$0.25−14.3%close to the price$366

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Meihao Medical Group Co.: 9 of 9 models see the stock below the current price.

HCA Healthcare: 6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Meihao Medical Group Co.
Price HK$0.54
Fair Value HK$0.37
Bear HK$0.28Bull HK$0.49
HCA Healthcare
Price $427
Fair Value $598
Bear $309Bull $841

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Meihao Medical Group Co. · Health Care

Quality score57 · above median
Fair value upside−31.5% · below median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+40.1% · Top 25%

Bottom line

As of Oct 1, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Meihao Medical Group Co. trades at HK$0.54 versus a fair value of HK$0.37 (−31.5%), while HCA Healthcare trades at $427 versus $598 (+40.1%).

HCA Healthcare has the higher quality score (70/100).

Open HCA Healthcare live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.